Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.86 |
| ▸ | MAPT | P10636 | 9/20 | 0.83 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.83 |
| ▸ | HPGD | P15428 | 6/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.83 |
| ▸ | TSHR | P16473 | 3/20 | 0.83 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | MAOB | P27338 | 2/20 | 0.83 |
| ▸ | HTT | P42858 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.71 |
| ▸ | MEN1 | O00255 | 8/20 | 0.71 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.69 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.69 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.69 |
| ▸ | CSNK2A3 | Q8NEV1 | 2/20 | 0.69 |
| ▸ | EGFR | P00533 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30695844 | 1.00 | MAOA (0.86) | MAOAMAPTTDP1ALDH1A1HPGD | |
| 1-Hydroxyanthraquinone SCHEMBL9317010 | 0.94 | MAPT (0.80) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Danthron SCHEMBL9317014 | 0.94 | MAPT (0.80) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Anthrarufin SCHEMBL11422341 | 0.93 | MAPT (0.83) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Anthrarufin SCHEMBL29874705 | 0.93 | MAOA (1.00) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Anthrarufin SCHEMBL29363946 | 0.93 | MAOA (1.00) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Anthrarufin SCHEMBL187843 | 0.93 | MAOA (1.00) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Anthrarufin SCHEMBL28419741 | 0.91 | MAOA (0.95) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Danthron SCHEMBL30544826 | 0.91 | MAPT (1.00) | MAOAMAPTTDP1ALDH1A1HPGD | |
| Danthron SCHEMBL29356886 | 0.91 | MAPT (1.00) | MAOAMAPTTDP1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-115537013-B | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2024-03-29 | — | — | CN | claimed |
| CN-115537013-A | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2022-12-30 | — | — | CN | claimed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-115537013-B | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| US-11786481-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| CN-115537013-A | Nuclear radiation resistant polyurethane elastomer material and preparation method thereof | 中国人民解放军海军工程大学 | 2022-12-30 | — | — | CN | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| US-11142827-B2 | Fluoride-free zirconium-based metal pre-treatment for passivation | HENKEL AG & CO. KGAA (DE) | 2021-10-12 | — | — | US | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-4746461-A | Method for preparing 1,4-diaminoanthraquinones and intermediates thereof | THE CLOROX COMPANY (US) | 1988-05-24 | — | — | US | disclosed |
| US-4661293-A | Method for preparing 1,4-diaminoanthraquinones and intermediates thereof | THE CLOROX COMPANY (US) | 1987-04-28 | — | — | US | disclosed |
| EP-0159357-A4 | CARMINOMYCINONE PRECURSORS AND ANALOGUES AND DERIVATIVES THEREOF. | UNIV MELBOURNE (AU) | 1986-04-15 | — | — | EP | disclosed |
| EP-0159357-A1 | CARMINOMYCINONE PRECURSORS AND ANALOGUES AND DERIVATIVES THEREOF. | UNIV MELBOURNE (AU) | 1985-10-30 | — | — | EP | disclosed |
| WO-1985001726-A1 | CARMINOMYCINONE PRECURSORS AND ANALOGUES AND DERIVATIVES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 1985-04-25 | — | — | WO | disclosed |
| US-4147706-A | Intermediates for polycyclic quinonoid antibiotics | RESEARCH CORPORATION (US) | 1979-04-03 | — | — | US | disclosed |
| US-4070382-A | DAUNOMYCINS, ANTITUMOR AGENTS | RESEARCH CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |
| US-4012284-A | STREPTOMYCES | Societa' Farmaceutici Italia, S.p.A. (IT) | 1977-03-15 | — | — | US | disclosed |
| US-3971740-A | DYES FOR POLYESTER FIBERS | CIBA-GEIGY AG (CH) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786481-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | MAOA 4700/4885MAPT 3534/4885TDP1 1811/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | MAOA 4389/4885MAPT 3091/4885TDP1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.